Real‐life comparison between secukinumab and ixekizumab in the treatment of pustular and erythrodermic psoriasis
Gianluca Avallone, Caterina Cariti, P. Dapavo, Michela Ortoncelli, L. Conforto, Luca Mastorino, Gabriele Roccuzzo, Francesco Cavallo, Marco Rubatto, Pietro Quaglino, Simone Ribero
Abstract
The authors report no conflict of interest. The data that support the findings of this study are available from the corresponding author upon reasonable request.
Topics & Concepts
SecukinumabIxekizumabMedicineDermatologyPsoriasisPustular psoriasisPsoriatic arthritisPsoriasis: Treatment and PathogenesisAutoimmune Bullous Skin DiseasesDermatology and Skin Diseases